| Literature DB >> 24440222 |
Sudhir K Dutta1, Mohit Girotra2, Shashank Garg3, Anand Dutta4, Erik C von Rosenvinge5, Cynthia Maddox6, Yang Song6, John G Bartlett7, Rakesh Vinayek8, W Florian Fricke9.
Abstract
The prevalence of recurrent Clostridium difficile infection (RCDI) is increasing; fecal microbiota transplantation (FMT) is an effective therapy. However, there have been no studies of the efficacy of a single session of combined enteral and colonic FMT or characterizations of changes in the microbiota between donors and recipients. We performed a study of 27 patients with RCDI who were given a fixed volume of processed fecal filtrate via enteroscopy and colonoscopy in a single session. Patients were closely monitored, and fecal samples were collected from 2 patient-donor pairs for 16S rRNA analysis. All patients had reduced stool frequency, abdominal pain, white blood cell counts, and elimination of fecal C difficile toxin (P < .05). FMT increased microbial diversity, increasing proportions of Lachnospiraceae (phylum Firmicutes) and reducing proportions of Enterobacteriaceae. FMT was associated with marked changes in the composition of fecal microbiota in 2 patients with RCDI.Entities:
Keywords: 16s rRNA Analysis; Clostridium difficile; Colonic; FMT; Fecal Microbiota Transplantation; Jejunal; Lachnospiraceae; Microbiota; RCDI; Recurrent
Mesh:
Year: 2014 PMID: 24440222 DOI: 10.1016/j.cgh.2013.12.032
Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN: 1542-3565 Impact factor: 11.382